| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3273534 | Journal de Gynécologie Obstétrique et Biologie de la Reproduction | 2007 | 4 Pages |
Abstract
Two patients, with prior affected children with Neonatal Haemochromatosis [NH], benefited from intravenous immunoglobulin treatment during their following pregnancy in order to prevent recurrent NH. Whereas NH is a severe disease with high risk of recurrence and high mortality rate (about 80%), a recent treatment was suggested in the USA, which seems to completely modify the prognosis of this pathology. We proposed this treatment for two patients with indeed apparent benefit, giving birth to two healthy babies.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
N. Carrabin, M.-P. Cordier, P. Gaucherand,